Fact Source: Financial Supervisory Service DART / 2025-09-05
Disclosure Type: Matters Related to Sustainability Report, etc. (Voluntary Disclosure)
💡 3-Second Summary
Samsung Biologics has issued a voluntary disclosure announcing that it has published its official ‘ESG Report 2025,’ which details its economic, social, and environmental achievements for the fiscal year 2024, and made it accessible on its official website following independent third-party verification.
📊 1. [Key Disclosure Content & Summary of Financial Figures]
- Company Name: Samsung Biologics Co., Ltd. (207940)
- Report Title: Samsung Biologics ESG Report 2025
- Assurance Provider: BSI (British Standards Institution) Group Korea
- Submission Location: Samsung Biologics Official Website (https://samsungbiologics.com/kr/sustainability/esg-report)
- Reporting Period: January 1, 2024 – December 31, 2024 (Certain material achievements include data up to the publication date in 2025; quantitative data tracks a 3-year trend from 2022 to 2024)
- Reporting & Assurance Standards: Prepared in accordance with GRI Standards 2021, referencing ISO 26000, UN Global Compact principles, SASB standards, ESRS, ISSB, TCFD, TNFD, and CDP recommendations. Verified under AA1000AS v3 and satisfies the 4 core principles of AA1000AP 2018.
- Main Table of Contents:
- I. MANAGEMENT REPORT (Letter to Stakeholders, Our Company, Our Business, Our Progress)
- II. STRATEGIC REPORT (Vision 2030, 3 Strategic Pillars, ESG Governance, Materiality Assessment)
- III. ESG PERFORMANCE REPORT (Corporate Governance, Risk Management, Environmental Impact Mitigation, Climate Change Response, Social Management)
- IV. ESG FACTBOOK (Financial & Non-Financial Performance, Third-Party Assurance Statement, GHG Verification Report)
📈 2. [Expert Insight: What This Disclosure Means for Investors]
This announcement represents a voluntary disclosure focusing on non-financial operational metrics rather than addressing short-term shifts in financial revenue or profitability. Consequently, it is likely to have a limited immediate impact on the company’s short-term stock price movements or direct financial fundamentals (Fundamental).
However, amidst the intensifying global regulatory environment regarding mandatory ESG disclosures and supply chain due diligence, this verified report holds analytical relevance as it aligns with demanding international standards such as GRI, ESRS, ISSB, and TCFD. Investors can utilize the provided repository link to evaluate the company’s non-financial risk management status, verified greenhouse gas emissions data, and corporate governance principles compliance to evaluate its mid-to-long-term operational sustainability.
📝 Editor’s Comment (by K-STOCK Editor)
Samsung Biologics has voluntarily disclosed the publication of its annual ESG report. Given that this filing contains no quantitative earnings surprises or commercial supply contracts, market participants should interpret this as a routine procedural disclosure aimed at transparency. The documentation contains verified third-party records regarding long-term corporate governance, risk monitoring, and environmental compliance mapped to evolving international standards. For long-term investors prioritizing the quality of non-financial compliance and risk architecture, examining the raw index and data inside the provided Factbook address is a recommended reference point.
📢 Disclaimer & Source Information
Source: This content has been structured and newly generated based on the official data submitted to the Financial Supervisory Service electronic disclosure system (DART).
Investment Risk Notice: This information is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
🔥 Bulls vs Bears, drop your analysis in the comments!
